Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
Huiyue Li, Jennifer K. Plichta, Kan Li, Yizi Jin, Samantha M. Thomas, Fei Ma, Li Tang, Qingyi Wei, You-Wen He, Qichen Chen, Yuanyuan Guo, Yueping Liu, Jian Zhang, Sheng Luo
Topics & Concepts
MedicineBreast cancerHazard ratioInternal medicineOncologyTriple-negative breast cancerProportional hazards modelOdds ratioCancerStage (stratigraphy)ChemotherapyCohortLogistic regressionConfidence intervalBiologyPaleontologyHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies